Skip to main content
. 2019 May 21:91–226. doi: 10.1007/978-94-024-1603-9_2

Table 2.2.

the main laboratory tests and the positive rate of them in severe hepatitis patients with blood coagulopathy

Name Changes Normal reference value Positive rate when severe hepatitis occurring (%)
 1. Tests about clotting factors
PT Lengthen 11–13 s 63–71
APTT >10s (37 ± 3.3)s 82–85
INR 1.0 ± 0.1 >80
HPT Decrease 90.1% ± 13.4% 93
Fz Decrease 2–4 g/L 16–20
Fγ:C Increase (103 ± 26)IU/L 100
TT >3 s 16–18 s
 2. Tests about anti-clotting factors
AT-β:A Decrease 108.5 ± 5.3% 100
PC:A Decrease 64–147% 84
 3. Tests about fibrinolysis
tPA Increase (0.3–0.6) IU/mL 92
PAI Decrease (0.1 ± 1.0)Au/mL 76
PLG:Ag Decrease (0.22 ± 0.03)g/L 56
PL;A

Fibrinolysis: increase

Hypercoagulability: Decrease

85.5% ± 27.83%
a2-PI Decrease 0.8–1.2 inhibitory units/mL 55
3P test Negative negative
ELT Shorten (<70 min)

Calcium addition method (129.8 ± 41.1)min

Enzymolysis method (157.5 ± 59.1)min

FDPs Decrease urine<10 mg/L 85–90
D-Dimer Increase

Negative (latex agglutination test)

0–0.256 mg/L (ELISA)

9–15
 4. Test about platelets quality and quantity
PLT Decrease (100–300) × 109/L
PAR Decrease

MAR (maximum aggregation rate)

ADP (1.0 mmol/L)62.7% ± 16.1%

ADP (0.5 mmol/L)37.4% ± 14.3%

Adrenaline (0.4 mg/L)67.85% ± 17.8%

PF3aT Decrease The recalcification time of group is under 5 s longer than that of group
CRT (whole blood method) Clot retraction rate 65.8% ± 11.0%; Clot retracts partly after 2 h, and retracts completely after 18–24 h